AIM:To study the therapeutic effects of transcatheter arterial three-segment chemoembolization for hepatocellular carcinoma (HCC). METHODS: According to the anatomy of vessels, the tumor capillary networks, muscular arterioles and feeding arteries were successively occluded using lipiodol ultra-fluid (LUF), sinobufagin microsphere (SBMs) and particles of gelatin sponge (PGS). In this series of 80 cases, therapeutic effects were evaluated in 76 cases. RESULTS: There were 22 cases (28.9%) with partial response and 41 (53.9%) with minor response in the 76 evaluated patients. The 6-month, 1-year, 2-year and 3-year survival rates were 97.4%, 86.8%, 46.1% and 27.6% respectively. CONCLUSION: This regimen was a rational chemoembolization method for HCC patients.
AIM:To study the therapeutic effects of transcatheter arterial three-segment chemoembolization for hepatocellular carcinoma (HCC). METHODS: According to the anatomy of vessels, the tumor capillary networks, muscular arterioles and feeding arteries were successively occluded using lipiodol ultra-fluid (LUF), sinobufagin microsphere (SBMs) and particles of gelatin sponge (PGS). In this series of 80 cases, therapeutic effects were evaluated in 76 cases. RESULTS: There were 22 cases (28.9%) with partial response and 41 (53.9%) with minor response in the 76 evaluated patients. The 6-month, 1-year, 2-year and 3-year survival rates were 97.4%, 86.8%, 46.1% and 27.6% respectively. CONCLUSION: This regimen was a rational chemoembolization method for HCCpatients.
Authors: T Beppu; C Ohara; Y Yamaguchi; T Ichihara; T Yamanaka; S Katafuchi; S Ikei; K Mori; S Fukushima; M Nakano Journal: Cancer Date: 1991-12-15 Impact factor: 6.860
Authors: Y Yamashita; M Takahashi; Y Koga; R Saito; S Nanakawa; Y Hatanaka; N Sato; K Nakashima; J Urata; K Yoshizumi Journal: Cancer Date: 1991-01-15 Impact factor: 6.860